The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

NCT06388720 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

82

Enrollment

OTHER_GOV

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Mitomycin-C
DRUG: gemcitabine

Sponsor

National Cancer Center, Korea